Pathways to Wellness
Boston, Massachusetts, 02118, United States
NCT Number: NCT00545623
The aims of the study are to investigate individual, combined and added effects of acupuncture and the relaxation response in reducing gastrointestinal symptoms, improving medication adherence and quality of life among people living with HIV/AIDS. The study will also explore the mechanism of these therapeutic effects of acupuncture and the relaxation response.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Boston, Massachusetts, 02118, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks
listening to CDs with verbal instructions of techniques to elicit relaxation response
sham acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks
Time frame: 8 weeks
We used the GI symptom subscale of the Revised HIV Sign and Symptom Checklist (SSC-HIV) to measure the intensity (0-10) of the six targeted GI symptoms: diarrhea, loose stools, gas/bloating, abdominal pain, nausea and vomiting, with 0 indicating no symptom and 10 indicating most sever symptom. Rating changes per intervention session were estimated using a mixed effects regression model controlling for baseline ratings. Data of loose stools are presented here.
Boston University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05911360
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Phoenix, Arizona, United States
View Trial DetailsNCT00164281
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Gaborone, Botswana
View Trial DetailsNCT04793750
Acquired Immunodeficiency Syndrome, Bacterial Infections
Baltimore, Maryland, United States
View Trial DetailsNCT00113282
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Paris, France
View Trial Details